PROGENICS PHARMACEUTICALS IN

CUSIP: 743187106 Class: CMN

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2020
Shares 25,005 Value ($000) $95 Avg Close Range
Q4 2019
Shares 69,683 Value ($000) $355 Avg Close Range
Q3 2019
Shares 164,740 Value ($000) $833 Avg Close Range
Q2 2019
Shares 82,131 Value ($000) $507 Avg Close Range
Q1 2019
Shares 39,120 Value ($000) $181 Avg Close Range
Q4 2018
Shares 271,647 Value ($000) $1,141 Avg Close Range
Q3 2018
Shares 7,046 Value ($000) $44 Avg Close Range
Q2 2018
Shares 4,049 Value ($000) $33 Avg Close Range
Q1 2018
Shares 118,044 Value ($000) $880 Avg Close Range
Q4 2017
Shares 2,847 Value ($000) $17 Avg Close Range
Q3 2017
Shares 26,047 Value ($000) $192 Avg Close Range
Q2 2017
Shares 11,818 Value ($000) $80 Avg Close Range
Q1 2017
Shares 11,950 Value ($000) $113 Avg Close Range
Q4 2016
Shares 43,337 Value ($000) $375 Avg Close Range
Q3 2016
Shares 29,076 Value ($000) $184 Avg Close Range
Q2 2016
Shares 42,146 Value ($000) $178 Avg Close Range
Q1 2016
Shares 16,550 Value ($000) $72 Avg Close Range
Q4 2015
Shares 127,771 Value ($000) $783 Avg Close Range
Q3 2015
Shares 15,800 Value ($000) $90 Avg Close Range
Q2 2015
Shares 7,100 Value ($000) $53 Avg Close Range
Q1 2015
Shares 5,100 Value ($000) $31 Avg Close Range
Q4 2014
Shares 5,400 Value ($000) $41 Avg Close Range